Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
708 (USA) · Dr. Kim
consented 2013-09-10
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ABDOMINAL PAIN — outcome: RECOVERED/RESOLVED; onset 2014-02-18 (study day 162.0); relationship: REMOTE
mild
assessed
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-12 (study day 3.0); relationship: PROBABLE
mild
assessed
Mild CONSTIPATION — outcome: RECOVERED/RESOLVED; onset 2014-02-18 (study day 162.0); relationship: REMOTE
mild
assessed
Mild MYOCARDIAL INFARCTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-23 (study day 14.0); relationship: REMOTE
Data queries
No data queries.